Abstract:Objective This study aimed to uncover the value of long noncoding RNA FGD5-AS1 (lncRNA FGD5-AS1) in the diagnosis of infantile pneumonia and explore its pathological mechanism in lung fibroblasts. This research may provide a potential biomarker for diagnosing patients and predicting their rehabilitation outcomes. Methods This study included 92 children with infantile pneumonia as the research object, and an equal number of healthy children were introduced as controls. The FGD5-AS1 content was detected using real-time quantitative polymerase chain reaction (RT-qPCR) assay. The diagnostic value of FGD5-AS1 was evaluated by receiver operating characteristic (ROC) and logistic analysis. The molecular mechanism of FGD5-AS1 and miR-223-3p was studied by luciferase activity assays. The impact of abnormal FGD5-AS1 expression on the proliferation and apoptosis of lung fibroblasts was analyzed using the cell counting kit-8 (CCK-8) and flow cytometry. Results FGD5-AS1 expression was decreased in the serum of infantile pneumonia patients, which may be a diagnostic marker for children with pneumonia. Furthermore, FGD5-AS1 has the ability to predict patient outcomes. FGD5-AS1 levels in lung fibroblasts (WI-38) decreased when induced by lipopolysaccharide (LPS). This decline resulted in reduced cell proliferation ability, increased apoptosis rate, and elevated inflammatory factor content. However, upregulated FGD5-AS1 counteracted the effects of LPS on WI-38 cells activity and inflammatory factors. Conclusion FGD5-AS1 may act as a potential marker in infantile pneumonia, and regulate the biological activity and inflammation level of lung fibroblasts by targeting miR-223-3p. Approval was obtained from the ethics committee of Longnan First People's Hospital. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Informed consent was obtained in writing from the parents or guardians. The datasets used and/or analyzed during this study are available from the corresponding author on reasonable request. The authors declare that they have no relevant financial or nonfinancial interests to disclose. H.P.R. developed the original idea and the protocol, abstracted and analyzed data, wrote the manuscript, and is a guarantor. H.L.W., Y.N.L., and L.C. contributed to the development of the protocol, abstracted data, and prepared the manuscript. Received: 22 December 2023 Accepted: 11 October 2024 Article published online: 16 November 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Pulmonary FABP4 is an inverse biomarker of pneumonia in critically ill children and adults

Integrating a host transcriptomic biomarker with a large language model for diagnosis of lower respiratory tract infection

Heart-type fatty acid-binding protein predicts the prognosis of pediatric severe pneumonia complicated by acute respiratory distress syndrome

Plasminogen Activation Inhibitor Concentrations in Bronchoalveolar Lavage Fluid Distinguishes Ventilator-Associated Pneumonia from Colonization in Mechanically Ventilated Pediatric Patients

THE CLINICAL CHARACTERISTICS AND PREDICTORS OF REFRACTORY MYCOPLASMA PNEUMONIAE PNEUMONIA IN CHILDREN

Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein

Deregulated Expression of Long Non-coding RNA ZFAS1 as a Predictive Biomarker for Respiratory Failure in Severe Pneumonia Children and Its Impact on Clinical Outcome

Proteomic profiling of the local and systemic immune response to pediatric respiratory viral infections

Metagenomic Next-Generation Sequencing of Bronchoalveolar Lavage Fluid from Children with Severe Pneumonia in Pediatric Intensive Care Unit

Biomarkers in pulmonary infections: a clinical approach

Decreased plasma fetuin-A level as a novel bioindicator of poor prognosis in community-acquired pneumonia: A multi-center cohort study

Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults

Expression and significance of procalcitonin, leukotriene B4, serum amyloid A, and C-reactive protein in children with different types of pneumonia: An observational study

Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial

A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia

A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR

Diagnostic Value of lncRNA FGD5-AS1 Sponge miR-223-3p in Infantile Pneumonia and Its Prognostic Effect on Rehabilitation

A Targeted Analysis of Serial Cytokine Measures and Nonpulmonary Organ System Failure in Children With Acute Respiratory Failure: Individual Measures and Trajectories Over Time

Heart-type Fatty Acid-Binding Protein Predict the Prognosis in Pediatric Patients with Sepsis and Septic Shock

Clinical Features and Biomarkers for Early Prediction of Refractory Mycoplasma Pneumoniae Pneumonia in Children

Low Serum Retinol-Binding Protein-4 Levels in Acute Exacerbations of Chronic Obstructive Pulmonary Disease at Intensive Care Unit Admission is a Predictor of Mortality in Elderly Patients